n-succinimidyl 3-(2-pyridyldithio)propionate has been researched along with Melanoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheung, LH; Marks, JW; Rosenblum, MG | 1 |
| Bartholomew, R; Cheung, L; Murray, JL; Rosenblum, MG | 1 |
| Foglesong, PD; Price, JO; West, WH; Winkler, MA | 1 |
3 other study(ies) available for n-succinimidyl 3-(2-pyridyldithio)propionate and Melanoma
| Article | Year |
|---|---|
Comparative cytotoxicity and pharmacokinetics of antimelanoma immunotoxins containing either natural or recombinant gelonin.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents, Phytogenic; Cross-Linking Reagents; Immunotoxins; Melanoma; Mice; Mice, Inbred BALB C; Mice, Nude; Plant Proteins; Protein Synthesis Inhibitors; Recombinant Proteins; Ribosome Inactivating Proteins, Type 1; Succinimides; Tumor Cells, Cultured | 1999 |
Antibody-mediated delivery of tumor necrosis factor (TNF-alpha): improvement of cytotoxicity and reduction of cellular resistance.
Topics: Animals; Antibodies, Monoclonal; Cell Survival; Dose-Response Relationship, Drug; Humans; Immunotoxins; Melanoma; Mice; Succinimides; Time Factors; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1991 |
Biodistribution and plasma survival in mice of anti-melanoma monoclonal antibody cross-linked to OKT3.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Neoplasm; Antigens, Differentiation, T-Lymphocyte; CD3 Complex; Cross-Linking Reagents; Disulfides; Drug Stability; Female; Half-Life; Immunotoxins; Melanoma; Mice; Mice, Inbred BALB C; Plasma; Receptors, Antigen, T-Cell; Succinimides; Tissue Distribution | 1990 |